Download PDF
Methods Inf Med 2006; 45(02): 211-215
DOI: 10.1055/s-0038-1634053
Original Article
Schattauer GmbH

Generic versus Disease-specific Instruments in Quality-of-life Assessment of Chronic Obstructive Pulmonary Disease

M. Malý
1   EuroMISE Centre and National Institute of Public Health, Prague, Czech Republic
,
V. Vondra
2   Pulmonary and Allergology Department, Prague, Czech Republic
› Author Affiliations
Further Information

Publication History

Publication Date:
06 February 2018 (online)

    Permissions and Reprints

Summary

Objectives: Chronic respiratory diseases may alter a patient’s social life and well-being. Measures of health-related quality of life have been proven to bring complementary information to functional assessments. The aim of the study was to describe the questionnaires that are most frequently used to measure this subjective construct in patients with chronic obstructive pulmonary disease (COPD) and to compare the responses obtained via administering one generic (SF-36) and one disease-specific questionnaire (St. George’s Respiratory Questionnaire; SGRQ) to patients with COPD.

Methods: One group of patients (46 individuals) was used to evaluate the questionnaire’s performance in repeated administrations under unchanged conditions (reproducibility) and to study the correlations of corresponding domains of respective questionnaires. Responsiveness of both questionnaires was tested on another group of 129 patients measured before and after the therapeutic stay at the spa. Methods of cor-relational analysis (Spearman, intraclass, and canonical correlation coefficients) as well as the Wilcoxon rank test were used for statistical analysis.

Results: Both questionnaires seem to be comprehensive outcome measures for patients with COPD, but some particular areas may not be covered with the same intensity (e.g. emotional problems). Reproducibility of both questionnaires was good and only small non-significant shifts were seen, particularly in physical and social functioning domains. In repeated measurement, the SGRQ seemed to be slightly more responsive to change than the SF-36.

Conclusions: The idea of using generic and disease-specific questionnaires together probably represents the best approach to this topic. It may improve our knowledge and explain better the relationship between disease-specific changes in patient status and both disease-specific treatment and general functional status.

Keywords

Health-related quality of life - questionnaires - chronic obstructive pulmonary disease - reproducibility - responsiveness
 

  • References

  • 1 Cox DR, Fitzpatrick R, Fletcher AE, Gore SM, Spiegelhalter DJ, Jones DR. Quality-of-life assessment: Can we keep it simple? With discussion. J R Statist Soc A 1992; 155: 353-93.
    CrossrefPubMedGoogle Scholar
  • 2 Ferrans CE, Powers MJ. Psychometric assessment of the Quality of Life Index. Res Nurs Health 1992; 15: 29-38.
    CrossrefPubMedGoogle Scholar
  • 3 Testa MA, Simonson DC. Assessment of quality of life outcomes. N Engl J Med 1996; 334: 835-40.
    CrossrefPubMedGoogle Scholar
  • 4 WHOQOL Group. The definition of quality of life and development of international quality of life assessment instruments. Soc Sci Med 1995; 41: 1403-409.
    CrossrefPubMedGoogle Scholar
  • 5 Patrick DL, Deyo RA. Generic and diseasespecific measures in assessing health status and quality of life. Med Care 1989; 27: S217-S232.
    CrossrefPubMedGoogle Scholar
  • 6 Ware JE, Sherbourne CD. The MOS 36-Item Short Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-81.
    CrossrefPubMedGoogle Scholar
  • 7 Stewart AL, Hays R, Ware JE. The MOS shortform general health survey. Reliability and validity in a patient popualtion. Med Care 1988; 26: 724-32.
    CrossrefPubMedGoogle Scholar
  • 8 Jenkinson C, Stewartbrown S, Petersen S, Paice C. Assessment of the SF-36 version 2 in the United Kingdom. J Epidemiol Community Health 1999; 53: 46-50.
    CrossrefPubMedGoogle Scholar
  • 9 Mahler DA, Mackowiak JI. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest 1995; 107: 1585-9.
    CrossrefPubMedGoogle Scholar
  • 10 Prieto L, Alonso J, Ferrer M, Anoto JM. Are results of the SF-36 health survey and the Nottingham Health Profile similar? A comparison in COPD patients. Quality of Life in COPD Study Group. J Clin Epidemiol 1997; 50: 463-73.
    CrossrefPubMedGoogle Scholar
  • 11 van Manen JG, Bindels PJ, Dekker FW. et al. The influence of COPD on health-related quality of life independent of the influence of comorbidity. J Clin Epidemiol 2003; 56: 1177-84.
    CrossrefPubMedGoogle Scholar
  • 12 Desikan R, Mason H. et al. Health related quality of life and healthcare resource utilization by COPD patients: A comparison of three instruments. Qual Life Res 2002; 11: 739-51.
    CrossrefPubMedGoogle Scholar
  • 13 Curtis JR, Deyo RA, Hudson LD. Health related quality of life among patients with chronic obstructive pulmonary disease. Thorax 1994; 49: 163-70.
    PubMedGoogle Scholar
  • 14 Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19: 787-805.
    CrossrefPubMedGoogle Scholar
  • 15 Jones P, Baveystock C, Littlejohns P. Relationship between general health measured with the sickness impact profile, pulmonary function, walking speed, respiratory symptoms and mood state in patients with chronic respiratory disease. Am Rev Respir Dis 1989; 140: 1538-83.
    CrossrefPubMedGoogle Scholar
  • 16 Hunt SM, McKenna SP, McEwen J, Williams J, Papp E. The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med 1981; 15: 221-9.
    PubMedGoogle Scholar
  • 17 Kaplan RM, Atkins CJ, Timms R. Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease. J Chron Dis 1984; 37: 85-95.
    CrossrefPubMedGoogle Scholar
  • 18 Jones PW, Quirk FH, Baveystock CM. The St George’s Respiratory Questionnaire. Respir Med 1991; 85 Suppl. B 25-31.
    CrossrefPubMedGoogle Scholar
  • 19 Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation – the St. George’s Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-7.
    CrossrefPubMedGoogle Scholar
  • 20 Guyatt GH, Berman LB, Townsend M, Puglsey SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773-8.
    CrossrefPubMedGoogle Scholar
  • 21 Hyland ME, Bott J, Singh S, Kenyon CA. Domains, constructs and the development of the breathing problems questionnaire. Qual Life Res 1994; 3: 245-56.
    CrossrefPubMedGoogle Scholar
  • 22 Streiner DL, Norman GR. Health Measurement Scales. A practical guide to their development and use. Oxford:: Oxford University Press; 1995
    Google Scholar
  • 23 Cella DF, Tulsky DS. Measuring quality of life today: Methodological aspects. Oncology 1990; 4: 29-38.
    PubMedGoogle Scholar
  • 24 Schuck P. Assessing reproducibility for interval data in health-related quality of life questionnaires: Which coefficient should be used?. Qual Life Res 2004; 13: 571-86.
    CrossrefPubMedGoogle Scholar
  • 25 Terwee CB, Dekker FW, Wiersinga WM, Prummel MF, Bossuyt PMM. On assessing responsiveness of health-related quality of life instruments: Guidelines for instrument evaluation. QualLife Res 2003; 12: 349-62.
    PubMedGoogle Scholar
  • 26 Johnson RA, Wichern DW. Applied Multivariate Statistical Analysis. Englewood Cliffs:: Prentice- Hall; 1982
    Google Scholar
  • 27 Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol 2003; 56: 52-60.
    CrossrefPubMedGoogle Scholar
  • 28 Engström CP, Persson LO, Larsson S, Sullivan M. Health-related quality of life in COPD: why both disease-specific and generic measures should be used. Eur Respir J 2001; 18: 69-76.
    CrossrefPubMedGoogle Scholar
  • 29 Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997; 155: 1283-9.
    CrossrefPubMedGoogle Scholar
  • 30 Tsukino M, Nishimura K, McKenna SP, Ikeda A, Hajiro T, Zhang M, Izumi T. Change in generic and disease-specific health-related quality of life during a one-year period in patients with newly detected chronic obstructive pulmonary disease. Respiration 2002; 69: 513-20.
    CrossrefPubMedGoogle Scholar
  • 31 Doll H, Duprat-Lomon I, Ammerman E, Sagnier PP. Validity of the St George’s respiratory questionnaire at acute exacerbation of chronic bronchitis: comparison with the Nottingham health profile. Qual Life Res 2003; 12: 117-32.
    CrossrefPubMedGoogle Scholar
  • 32 Okubadejo AA, Jones PW, Wedzicha JA. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax 1996; 51: 44-7.
    CrossrefPubMedGoogle Scholar
  • 33 McColl E, Eccles MP, Rousseau NS, Steen N, Paarkin DW, Grimshaw JM. From the generic to condition-specific? Instrument order effects in quality of life assessment. Med Care 2003; 41: 777-90.
    CrossrefPubMedGoogle Scholar